Inbiose
Universiteit Gent

Inbiose

Biotech
Biotech
Biotech
Biotech

Inbiose develops a fermentation-based production platform for the supply of specialty carbohydrates addressing wellness, nutrition, AgBio and BioMed needs.

Inbiose was founded mid 2013 as a spin-off from Ghent University. Inbiose develops a versatile fermentation-based production platform for the supply of specialty carbohydrates addressing wellness, nutrition, AgBio and BioMed needs. Specialty carbohydrates are high value added, rare and complex carbohydrates that are extremely hard to produce with conventional technologies (extraction, chemical or enzymatic synthesis). Though these powerful ingredients have been found to be essential for improving health in many areas, applications were hampered until today by the production cost and very limited availability. Inbiose can now tackle these technological issues, giving strong and reliable market perspectives.

No items found.
Marc Zabeau

Marc Zabeau

Managing Partner Qbic I

This company is aligned with the following SDGs

No items found.
VoxelSensors
Qbic III
Deeptech
Deeptech
Deeptech
Deeptech

VoxelSensors

VoxelSensors is developing ultra-low power and ultra-low latency 3D perception sensors for Extended Reality.

VUB
Abscint
Qbic II
Biotech
Biotech
Biotech
Biotech

Abscint

ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.

VUB
UZ Brussel
THERAtRAME
Qbic III
Biotech
Biotech
Biotech
Biotech

THERAtRAME

THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.

ULiège